Mass spectrum identification method for O-GalNAc glycosylation modified peptide fragment in proteolysis solution
By matching Y ion appearance patterns and database search in O-glycopeptide mass spectrometry, the problem of long search time and low sensitivity in O-glycosylated peptide identification was solved, and high sensitivity and high reliability O was achieved -Glycosylated proteomics research, suitable for the analysis of complex biological samples.
Patent Information
- Application Number
- CN202310606012.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-26
- Publication Date
- 2024-11-26
AI Technical Summary
When identifying O-glycosylated peptides, the search time is long, the sensitivity and credibility are low, especially due to the expansion of the search space caused by the complexity and diversity of the core structure of O-glycosylation modification, which is difficult to effectively utilize. Y ion information in the spectrum.
By matching the Y ion appearance pattern in the O-glycopeptide mass spectrometry spectrum, the search types of O-glycosylation modifications were simplified, and high sensitivity and high reliability identification were performed using Q-Exactive mass spectrometer and MS-Decipher software, combined with Yn ion combination mode and database retrieval reduces the search space and improves identification efficiency.
Achieve high sensitivity and high reliability of O-glycosylated protein mass spectrometry data, suitable for O-glycosylated proteomics research in complex biological samples, and improve the identification of O-GalNAc complete glycosylated modified peptides efficiency.
Smart Images

Figure BDA0004250589750000061 
Figure BDA0004250589750000071 
Figure BDA0004250589750000081
Abstract
Description
Technical Field
[0001] The present invention relates to the identification of O-GalNAc complete glycosylated peptide segments in human serum, and in particular to a method for automatically and rapidly identifying highly sensitive O-GalNAc complete glycosylated peptide segments by using liquid chromatography-tandem mass spectrometry in disease marker research. Background Art
[0002] Protein glycosylation is one of the most complex post-translational modifications of proteins (Reference 2. Hart, GW; Copeland, RJ 2010. Glycomics Hits the Big Time. Cell 143: 672–676.). Among them, N-glycosylation on asparagine and O-glycosylation on serine, threonine or tyrosine are the two most common types. Protein glycosylation is closely related to physiological processes, making glycosylated proteins have the potential to become disease markers. Unlike the pentasaccharide core structure of N-glycosylation, O-glycosylation has a wider range of core structures and often has multiple modification sites on the same peptide (Reference 3. Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. 2015. Essentials of Glycobiology. In: Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. (Eds.) 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY).), which makes the analysis of O-glycosylated peptides more difficult.
[0003] In traditional methods, mass spectrometry data for identifying O-glycosylated peptides is retrieved by setting O-glycosylation modification as a variable modification in database searches. However, the increase in the number of glycosylation modification types and sites considered by this method will greatly increase the search space, resulting in increased search time and decreased sensitivity and reliability. The O-Search method developed in 2019 (Reference 4. Mao, J.; You, X.; Qin, H.; Wang, C.; Wang, L.; Ye, M. 2019. A New Searching Strategy for the Identification of O-Linked Glycopeptides. Analytical Chemistry 91: 3852–3859.) ignores the unreliable site information in the spectrum obtained by the high-energy collision dissociation (HCD) mode of mass spectrometry, and regards all glycosylation modifications on glycosylated peptides as mass tags (delta mass) at the peptide level, thereby greatly simplifying the information that needs to be considered when searching the database. This retrieval method was later integrated into the protein mass spectrometry database retrieval software MS-Decipher developed by us (Reference 1. Mao, J.; Zhu, H.; Liu, L.; Fang, Z.; Dong, M.; Qin, H.; et al. 2022. MS-Decipher: a user-friendly proteomedatabase search software with an emphasis on deciphering the spectra of O-linked glycopeptides. Bioinformatics 38:1911–1919.).Later, some software also used similar methods to search for O-glycopeptides, such as MSFragger-Glyco (Reference 5. Polasky, DA; Teo, GC; Nesvizhskii, AI 2020. Fast and comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco. Nature Methods.), MetaMorpheus (Reference 6. Lu, L.; Riley, NM; Shortreed, MR; Bertozzi, CR; Smith, LM 2020. O-Pair Search with MetaMorpheus for O-glycopeptide characterization. Nature Methods 17: 1133–1138.) and pGlyco3 (Reference 7. Zeng, W.-F.; Cao, W.-Q.; Liu, M.-Q.; He, S.-M.; Yang, P.-Y. 2021. Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans withpGlyco3. Nature Methods 18:1515–1523.).
[0004] After that, our work focused on studying how to further simplify the types of glycosylation modification types that can be retrieved. The previous O-Search method only used the peptide backbone fragment ions in the spectrum for identification, while ignoring the information provided by other ions, such as the Y ion (the complete peptide ion with partial glycosylation modification). The glycosylation modification type of N-glycosylated peptides can be obtained by matching the N-glycosylated pentasaccharide core peak in the spectrum, calculating the mass difference between the Y1 peak (peptide ion with a HexNAc sugar modification) and the parent ion, and then comparing the mass difference with the modification mass in the glycosylation modification database to be searched. Unlike N-glycosylation modification, the core structure of O-glycosylation modification is more complex, and multiple glycosylation modifications may occur on the same glycopeptide; this makes the appearance and distribution of Y ions in the spectrum of O-glycopeptides less regular than that of N-glycopeptides.
[0005] However, the Y ions in the spectrum of O-glycopeptides can still provide information for identification. Although O-glycosylation modification has a more complex core structure and more sites, for a specific modification, the possible Y ions can still be obtained by enumerating a limited number of cases. These possible Y ions are arranged and combined to form a "Y-ion pattern" composed of several Y ions, similar to the pentasaccharide core peak of N-glycopeptides, and then the method of identifying N-glycopeptides is used to match and search in the O-glycopeptide spectrum, which can reduce the search space of glycosylation modification to a certain extent and improve sensitivity.
[0006] We developed a database search method for O-glycopeptide spectra based on the above method and integrated it into our database search software MS-Decipher. Through performance testing on human serum O-glycopeptide datasets and comparison with other software, the high sensitivity and high reliability advantages of this method were revealed, and it can be applied to the study of O-glycosylation proteomics in complex biological samples. Summary of the invention
[0007] The purpose of the present invention is to provide a highly sensitive and reliable method for identifying O-glycosylated protein mass spectrometry data. The present invention utilizes the information provided by Y ions in the mass spectrometry of O-glycopeptides, simplifies the search types of O-glycosylation modifications by matching the Y ions that appear, and improves the sensitivity and reliability of identification. The method has high sensitivity and high reliability and can be applied to the omics study of O-GalNAc glycosylated proteins.
[0008] The present invention adopts the following technical solution:
[0009] 1) The chromatographic and mass spectrometric data of O-glycopeptides were obtained using the O-glycopeptide enrichment analysis method (Reference 1. Mao, J.; Zhu, H.; Liu, L.; Fang, Z.; Dong, M.; Qin, H.; et al. 2022. MS-Decipher: a user-friendly proteome database search software with an emphasis on deciphering the spectra of O-linked glycopeptides. Bioinformatics 38: 1911–1919.); the difference is that the mass spectrometer used was Q-Exactive model (Thermo Fisher Scientific FIC Company, USA), after the sample is loaded into the chromatographic column, a mobile phase with a concentration of 0.1% formic acid is used as a phase A solution, and a mobile phase with a concentration of 80% acetonitrile / 0.1% trifluoroacetic acid is used as a phase B solution; in the experimental method, during the 110-minute gradient elution process, the mass concentration of the mobile phase is first maintained at 4% for 10 minutes, then the concentration is gradually increased from 4% to 45% within 78 minutes, and then the concentration is gradually increased from 45% to 90% within 2 minutes, and the concentration is maintained at 90% for 10 minutes, and finally gradually decreased to 4% within 10 minutes; for mass spectrometry analysis, energy fragmentation uses step-normalized HCD fragmentation energies of 20, 30, and 40.
[0010] The general steps are as follows: using the protease hydrolysate in human serum as the loading sample, using PNGase F to remove the N-glycosylation modification attached to the glycosylated peptide segment, enriching it using a hydrophilic interaction chromatography column, and then analyzing it using liquid chromatography tandem mass spectrometry to obtain chromatograms and chromatographic data;
[0011] 2) Spectrum screening and pretreatment: First, two common oxonium ions (Hex + , mass-to-charge ratio 138.054; HexNAc + , mass-to-charge ratio 204.087) to screen for mass spectra with one of these two ions and signal intensity ranking in the top 10%. Then all oxonium ion peaks in these spectra are matched and removed to reduce interference with subsequent data processing;
[0012] 3) Based on the artificially set O-GalNAc glycosylation modification database for retrieval, enumerate the possible Yn (n is the number of sugar units in the glycosylation modification on the peptide) ion types for each glycosylation modification; then arrange and combine these Y ions, with three Yn ions with different n values as a group, and there must be a Y0 ion (complete peptide backbone ion) to form a combination of Y ions (Y-ion pattern); these patterns exist in the form of mass difference;
[0013] O-GalNAc glycosylation is connected to the peptide through a HexNAc. For all O-GalNAc glycosylated peptides, the Y1 ion that appears in the spectrum can only be in the form of "peptide ion + HexNAc (1)". For all O-GalNAc glycosylated peptides, this ion may appear in their spectra (because the number of glycosylation units in glycosylation modification is at least 1). For Y2 and Y3 ions, their structures can only be "peptide ion + HexNAc (1) + one glycosylation unit". and "peptide ion + HexNAc(1) + two glycosylation units". For example, for the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), its Y1 ion has only one form, "peptide ion + HexNAc(1)", its Y2 ion has two forms, "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)", and its Y3 ion has only one form, "peptide ion + Hex(1)HexNAc(1)NeuAc(1)".
[0014] For O-glycosylation modification Hex(1)HexNAc(1), the Y1 ion that may appear in the secondary spectrum of the glycopeptide with this glycosylation is the peptide ion with HexNAc(1), and its mass is “peptide ion mass (Y0 mass) + HexNAc(1) mass”; the Y2 ion that may appear is the peptide ion with Hex(1)HexNAc(1), and its mass is “peptide ion mass + Hex(1)HexNAc(1) mass”; then for this glycosylation modification, the “Y ion appearance pattern” refers to the complete O-glycopeptide ion. The appearance pattern is composed of three ions: [Y0 ion, Y1 ion, Y2 ion]; for other glycosylation modifications, the masses of Y1 and Y2 ions may be different, and for glycosylation modifications containing three or more glycosylation units, there may be a Y3 ion (peptide ion with three glycosylation units, such as "peptide ion + Hex(1)HexNAc(1)NeuAc(1)"), and the appearance patterns of [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] may also be formed;
[0015] In the method described in this patent, the ions listed in the "occurrence pattern" are only ion types. For example, "Y2 ion" refers only to the complete peptide ion with two sugar units, while its specific structure may be in multiple situations. For example, for a peptide with the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), there are two possible Y2 ions, namely "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)".
[0016] The method described in this patent studies the appearance pattern of Y ions in O-glycosylated O-glycopeptides with 2 or more glycosylated units. O-glycosylated O-glycopeptides with only one glycosylated unit (such as HexNAc(1)) are not within the scope of this method because Yn ions with n greater than or equal to 2 cannot appear in the spectrum of such glycosylated glycopeptides. In the Y ion appearance pattern studied in the method described in this patent, the maximum value of n in Yn ions is 3. For O-glycosylated O-glycopeptides with only two glycosylated units, such as Hex(1)HexNAc(1), only the appearance pattern of [Y0 ion, Y1 ion, Y2 ion] is considered. For O-glycosylated O-glycopeptides with three or more glycosylated units, the three appearance patterns of [Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] are considered.
[0017] 4) Match the Y ion appearance pattern in the screened O-glycopeptide spectra. When three spectral peaks are matched with the combined appearance pattern of the Y ions, calculate the mass difference between the minimum mass peak and the parent ion of the spectrum, and compare it with the glycosylation modification mass in the glycosylation modification database; if they are equal, put the glycosylation modification into the candidate;
[0018] 5) Based on the candidate glycosylation modifications, the O-glycopeptide spectra were searched in the database using the MS-Decipher software developed by us; for the O-glycopeptide spectra that could not obtain the results and the spectra that did not match the Y ion appearance pattern in step 4), all O-glycosylation modifications in the O-glycosylation modification database were used for database search;
[0019] 6) Combine all database search results from the previous step and calculate the false positive rate of the results using percolator software;
[0020] 7) Obtaining O-glycopeptide spectrum identification results with a false positive rate of ≤1%;
[0021] Additional information for the program:
[0022] a. The experimental method described in step 1) is basically similar to the method used in our previously published paper (Reference 1. Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. 2015. Essentials of Glycobiology. In: Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. (Eds.) 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY).), except that: the mass spectrometer used was Q-Exactive model (Thermo Fisher Scientific FIC, USA), and after the sample was loaded onto the chromatographic column, a mobile phase with a concentration of 0.1% formic acid was used as the phase A solution, and a mobile phase with a concentration of 80% acetonitrile / 0.1% trifluoroacetic acid was used as the phase B solution;
[0023] b. In the experimental method described in step 1), during the 110-minute gradient elution process, the mass concentration of the mobile phase was first maintained at 4% for 10 minutes, then gradually increased from 4% to 45% within 78 minutes, then gradually increased from 45% to 90% within 2 minutes, maintained at 90% for 10 minutes, and finally gradually decreased to 4% within 10 minutes;
[0024] c. Step 1) Mass spectrometry analysis: energy fragmentation uses step-normalized HCD fragmentation energies of 20, 30, and 40.
[0025] d. Step 3) wherein the value of n in the Yn ion is at most 3;
[0026] e. Step 3) wherein the highest valence state of the Yn ion is the parent ion valence state;
[0027] f. Step 5) The MS-Decipher software version is 1.0.1, which can be obtained at https: / / github.com / DICP-1809 / MS-Decipher;
[0028] g. Step 6) The percolator software version is 3.6, which is free software and can be obtained at https: / / github.com / percolator / percolator / releases;
[0029] h. Step 7) The PSM results are obtained by screening the q-value and peptide q-value calculated by the percolator software to be less than or equal to 0.01, and the Rank Score calculated by the MS-Decipher software to be greater than or equal to 20;
[0030] Advantages of the present invention:
[0031] This method uses the information of Y ions in the spectrum, which is rarely used in common O-glycopeptide search methods, to screen candidate glycosylation modifications, reducing the search space for glycosylation modifications and improving the sensitivity of the search. This method can be applied to the study of O-glycosylation proteomics in complex biological samples and has great potential for discovering new O-glycopeptides.
[0032] The present invention is a mass spectrometry data identification method for O-GalNAc complete glycosylation modified peptide segments based on the appearance pattern of complete peptide segment ions (Y ions) with partial sugar chain modifications in the matching mass spectrometry spectrum, which is used to efficiently and reliably identify the spectrum information of O-GalNAc complete glycosylation modified peptide segments from high performance liquid chromatography-multi-stage tandem mass spectrometry data. The method enumerates the Y ions that may appear on the O-GalNAc glycosylation modified peptide segments, and combines these ions into the appearance pattern of Y ions in the form of a group of three, and matches these appearance patterns in the mass spectrometry spectrum to reduce the search space of the candidate glycosylation modification to be retrieved. Compared with the currently common identification software for O-complete glycosylation modified peptide segments, the advantage of the present invention is that it can obtain highly sensitive and highly reliable identification results of O-GalNAc complete glycosylation modified peptide segments, which is suitable for high-throughput analysis and large-scale identification. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 The figure is a flow chart for the mass spectrometry data identification of O-GalNAc intact glycosylated peptides based on matching the appearance pattern of intact peptide ions with partial sugar chain modifications in the mass spectrometry spectrum.
[0034] Figure 2 The figure shows the performance comparison between this method and several other commonly used O-glycosylated peptide identification software. DETAILED DESCRIPTION
[0035] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples.
[0036] Example:
[0037] The glycosylation proteomics analysis method based on hydrophilic interaction chromatography coupled to microflow liquid chromatography tandem mass spectrometry was used for the separation and detection of glycosylated peptides in human plasma samples. The specific experimental process is as follows (the process is as attached to the instruction manual). Figure 1 ):
[0038] (1) Take 5 μL of serum sample (protein concentration 60 mg / ml) from a mixed healthy person (equal volume of serum from ten males and ten females aged between 20 and 70 years old) and dilute it with 45 μL of 0.1 M ammonium bicarbonate buffer solution (pH 7.8) containing 8 M urea; add dithiothreitol to a final concentration of 0.02 M and react in a 37°C water bath for 2 h; then add iodoacetamide to a final concentration of 0.02 M and react in a dark environment at room temperature for 40 min; dilute the urea in the solution to a concentration of 2 M with 0.1 M ammonium bicarbonate buffer solution (pH 7.8), add 12 μg of trypsin to enzymatically hydrolyze serum protein, and react at 37°C for 15 h to obtain a serum protease peptide solution (serum protein);
[0039] (2) The serum protein obtained by enzymatic hydrolysis in step (1) was dissolved in 100 μL of 0.05 M sodium phosphate buffer (pH 7.5) solution containing 150 u PNGase F enzyme to remove N-glycosylation modification, and the reaction was carried out in a 37° C. water bath for 16 h to obtain a serum protease hydrolyzed peptide solution without N-glycosylation;
[0040] (3) After the reaction in step (2) was completed, 12 μL of a 20% TFA (trifluoroacetic acid) acidified solution was added to the solution to terminate the enzyme reaction, and the obtained enzymatic solution was desalted using a C18 analytical column (Waters, with a filler particle size of 2 μm and a chromatographic column specification of 1×150 mm), and eluted using 600 μL of a 0.1% TFA / 80% ACN (acetonitrile) aqueous solution as an eluent, and the desalted eluent was collected as the eluted serum protease peptide fragments, which were freeze-dried and stored in a -20°C refrigerator for later use, thereby obtaining desalted and freeze-dried serum protease peptide fragments;
[0041] (4) The lyophilized serum proteolytic peptides obtained in step (3) were redissolved in 36 μL of 0.1% TFA / 80% ACN (acetonitrile) aqueous solution, and then 5 μL was automatically injected using an automatic injection system at a flow rate of 200 μL / min. The solution containing the proteolytic peptides was first loaded onto a hydrophilic interaction chromatography column (the filler was click maltose microsphere filler synthesized according to the literature (Reference 8. Yu, L.; Li, X.; Guo, Z.; Zhang, X.; Liang, X. Hydrophilic Interaction Chromatography Based Enrichment of Glycopeptides by Using ClickMaltose: A Matrix with High Selectivity and Glycosylation Heterogeneity Coverage. Chemistry–A European Journal 2009,15(46),12618–12626.), the filler particle size is 5 μm, and the specification of the chromatographic column is 2.1 mm (inner diameter) × 50 mm (length); the elution mobile phase consists of (volume concentration) mobile phase A (0.1% TFA aqueous solution) and mobile phase B (0.1% TFA / 98% ACN aqueous solution); the elution program is set as follows (volume ratio): 82% B from 0 to 11 minutes, 30% B from 11 to 13 minutes, 0% B from 13 to 15 minutes, 82% B from 15 to 20 minutes; the effluent of 12-13 minutes is collected as the enriched serum glycosylated peptides, which are freeze-dried and stored in a -20°C refrigerator for future use; this step obtains serum glycosylated peptides (serum glycopeptides);
[0042] (5) The serum glycopeptides obtained in step (4) were redissolved in 20 μL of 0.1% (the following are all volume concentrations) formic acid solution, and then loaded onto a Q-Exactive (Thermo Fisher Scientific, USA) liquid chromatography-mass spectrometer. The solution containing the intact glycopeptides was first loaded onto a C18 chromatographic column (same as step (3), Waters, with a filler particle size of 2 μm and a chromatographic column specification of 1×150 mm), and then the concentration of the acetonitrile phase was increased to start separation and detection of glycopeptides for LC-MS / MS analysis; a mobile phase with a volume concentration of 0.1% formic acid was used as the A phase solution, and a volume concentration of 80% acetonitrile / 0.1% trifluoroacetic acid was used as the B phase solution; during the 110-minute gradient elution process, the volume ratio of mobile phase B was first maintained at 4% for 10 minutes, and then the concentration was gradually increased from 4% to 45% within 78 minutes. , then gradually increase the concentration from 45% to 90% within 2 minutes, maintain 90% concentration for 10 minutes, and finally gradually reduce it to 4% within 10 minutes; the mass spectrometry analysis energy fragmentation adopts step-normalized HCD fragmentation energy 20, 30, 40; finally, three MS-Run data files are obtained, containing a total of 103,335 mass spectra, including 14,072 primary spectra and 89,263 secondary spectra; (6) For the secondary mass spectra obtained in step (5), firstly, all mass peaks in each secondary spectrum are sorted from high to low according to signal intensity; for each secondary spectrum, if there are two oxonium ion peaks (Hex + (Hexose), mass-to-charge ratio 138.054; HexNAc + (N-acetylhexosamine), mass-to-charge ratio 204.087), and the signal intensity value of at least one of these two ion peaks is in the top 10% of all mass spectrum peaks in the signal intensity ranking of this secondary spectrum. This secondary mass spectrum is regarded as the O-glycopeptide spectrum to be processed; a total of 68,641 such spectra were screened, and these secondary spectra were used for subsequent identification;
[0043] (7) The three most common O-glycosylation modifications on O-glycopeptides in human serum (Hex(1)HexNAc(1), Hex(1)HexNAc(1)NeuAc(1), Hex(1)HexNAc(1)NeuAc(2), where NeuAc is sialic acid), and each O-glycopeptide is considered to have a maximum of three glycosylation modifications, and 15 O-glycosylation modification compositions are obtained by permutation and combination (see the table below); these O-glycosylation modification compositions are used as the O-glycosylation modification database to be searched; the protein database is used from https: / / www.uniprot.org / The human proteome database (version number: 20190322) downloaded from the website; the glycosylation database and the human proteome database were used to generate subsequent theoretical spectra;
[0044]
[0045]
[0046] (8) The glycosylation unit may be one or more of hexose (Hex), HexNAc (N-acetylhexosamine), and sialic acid (NeuAc);
[0047] First, by enumerating the appearance patterns of all possible complete peptide ions with partial glycosylation modifications (hereinafter referred to as "Y ions") in the mass spectrometry of O-GalNAc glycosylated peptides (hereinafter referred to as "O-glycopeptides"), the peptide ions include Y0, Y1 to Yn ions with 0 to n glycosylation units; n is an integer greater than or equal to 2, and 0, 1 or n respectively represent the number of glycosylation units in the peptide ions;
[0048] "Yn" ion refers to a peptide ion with n glycosylation units, where n refers to the number of glycosylation units on the peptide in the ion; n is an integer greater than or equal to 2. In particular, Y0 ion refers to the complete peptide backbone ion (peptide ion) of O-glycopeptide. In theory, Y0 may appear in all glycopeptide spectra; Yn ion theoretically only appears in glycosylation-modified glycopeptide spectra with n glycosylation units.
[0049] According to the structure of O-GalNAc glycosylation modification, O-GalNAc glycosylation is connected to the peptide through a HexNAc (N-acetylhexosamine). Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". For all O-GalNAc glycosylated peptides, this ion may appear in their spectra.
[0050] As for the Yn ion, its structure can only be "peptide ion + HexNAc (1) + (n-1) glycosylation unit";
[0051] The occurrence pattern of "Y ions" only considers the Y0 ion and any other Y with different X values. X ion, X is an integer from 1 to n;
[0052] For O-glycosylated glycopeptides, the Y1 ion that may appear in the secondary spectrum is the peptide ion connected to HexNAc (1), and the mass of the Y1 ion is "the mass of the peptide ion (Y0 mass) + the mass of HexNAc (1)". X The ion mass is “peptide ion mass (Y0 mass) + mass of X glycosylation units including HexNAc (1)”;
[0053] O-GalNAc glycosylation is linked to the peptide through a HexNAc. Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". This ion may appear in the spectrum of all O-GalNAc glycosylated peptides. As for the Y2 and Y3 ions, their structures can only be "peptide ion + HexNAc (1) + a glycosylation unit" and "peptide ion + HexNAc (1) + a glycosylation unit", respectively. (1) + two glycosylation units". For example, for the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), its Y1 ion has only one form, "peptide ion + HexNAc(1)", its Y2 ion has two forms, "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)", and its Y3 ion has only one form, "peptide ion + Hex(1)HexNAc(1)NeuAc(1)".
[0054] For O-glycosylation modification Hex(1)HexNAc(1), the Y1 ion that may appear in the secondary spectrum of the glycopeptide with this glycosylation is the peptide ion with HexNAc(1), and its mass is “peptide ion mass (Y0 mass) + HexNAc(1) mass”; the Y2 ion that may appear is the peptide ion with Hex(1)HexNAc(1), and its mass is “peptide ion mass + Hex(1)HexNAc(1) mass”; then for this glycosylation modification, the “Y ion appearance pattern” refers to the complete O-glycopeptide ion. The appearance pattern is composed of three ions: [Y0 ion, Y1 ion, Y2 ion]; for other glycosylation modifications, the masses of Y1 and Y2 ions may be different, and for glycosylation modifications containing three or more glycosylation units, there may be a Y3 ion (peptide ion with three glycosylation units, such as "peptide ion + Hex(1)HexNAc(1)NeuAc(1)"), and the appearance patterns of [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] may also be formed;
[0055] In the method described in this patent, the ions listed in the "occurrence pattern" are only ion types. For example, "Y2 ion" refers only to the complete peptide ion with two sugar units, while its specific structure may be in multiple situations. For example, for a peptide with the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), there are two possible Y2 ions, namely "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)".
[0056] The method described in this patent studies the appearance pattern of Y ions in O-glycosylated O-glycopeptides with 2 or more glycosylated units. O-glycosylated O-glycopeptides with only one glycosylated unit (such as HexNAc(1)) are not within the scope of this method because Yn ions with n greater than or equal to 2 cannot appear in the spectrum of such glycosylated glycopeptides. In the Y ion appearance pattern studied in the method described in this patent, the maximum value of n in Yn ions is 3. For O-glycosylated O-glycopeptides with only two glycosylated units, such as Hex(1)HexNAc(1), only the appearance pattern of [Y0 ion, Y1 ion, Y2 ion] is considered. For O-glycosylated O-glycopeptides with three or more glycosylated units, the three appearance patterns of [Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] are considered.
[0057] (A) For glycosylation modifications with a glycosylation unit number of not less than 3 (n≥3): (Hex(1)HexNAc(1)NeuAc(2),Hex(2)HexNAc(2)NeuAc(2),Hex(3)HexNAc(3)NeuAc(2),Hex(2)HexNAc(2)NeuAc(3),Hex(3)HexNAc(3)NeuAc(3),Hex(1)HexNAc(1)NeuAc(1),Hex(2)HexNAc(2)NeuAc(3) x(2)HexNAc(2)NeuAc(1),Hex(3)HexNAc(3)NeuAc(1),Hex(3)HexNAc(3)NeuAc(6),Hex(2)HexNAc(2)Ne uAc(4),Hex(3)HexNAc(3)NeuAc(4),Hex(3)HexNAc(3)NeuAc(5),Hex(2)HexNAc(2),Hex(3)HexNAc(3)):
[0058] (A-1) Based on the glycosylation modifications in step (7), list all possible Yn ions (Yn ions refer to complete peptide ions with partial glycosylation modifications, n represents the number of sugar units attached to the peptide ion, see the table below; Y1 to Y3 ions are listed here);
[0059]
[0060]
[0061] These ions with different n values are combined in pairs with the Y0 ion (complete peptide backbone ion) to form the Y ion appearance pattern (see the table below); this step obtains different Y ion appearance patterns ([Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion], which are used to match the peaks in the spectrum later. The matching process is shown in the next step;
[0062]
[0063]
[0064] (A-2) The Y1 ion that may appear in the secondary spectrum of an O-glycosylated glycopeptide is the peptide ion linked to HexNAc(1), and the mass of the Y1 ion is “the mass of the peptide ion (Y0 mass) + the mass of HexNAc(1)”; X The ion mass is “peptide ion mass (Y0 mass) + mass of X glycosylation units including HexNAc (1)”; the Y values of the two different X values in these occurrence patterns are X The mass difference between the ion and the Y0 ion (two mass differences) is matched with the mass difference between the two larger mass peaks minus the smallest mass peak among all three peaks in the secondary spectrum;
[0065] Match these two mass differences with the mass differences between all the peaks in the secondary spectrum. If the mass differences between the two unique three peaks are equal to the mass differences between the two ions in the appearance pattern, then the three peaks are considered to match the appearance pattern.
[0066] For example, if three peaks appear in a secondary spectrum that conform to a certain Y ion appearance pattern (for example, a spectrum has three peaks with masses of 500, 703.079, and 906.159 Da, respectively), the mass difference between the first two peaks is 203.079 Da, and the mass difference between the first and third peaks is 406.159 Da. In the third row of the table above, the mass difference between the first two ions (Y0 and Y1) is also 203.079 Da (because the Y0 ion is not connected to a glycosylation modification, while the Y1 ion is connected to a glycosylation modification with a mass of 203.079 Da, and the masses of the peptide segments of the two are equal), and the mass difference between the first and third ions (Y0 and Y2) is also 406.159 Da. 6.159Da, these three peaks match the three ions in the first row of the table above), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da), compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum;
[0067] If there are three peaks with masses of 500, 703.079, and 1109.238Da in a secondary spectrum, the mass difference between the first two peaks is 203.079Da, and the mass difference between the first and third peaks is 609.238Da. The mass difference between the first two ions (Y0 and Y1) in the seventh row of the table above is also 203.079Da (because the Y0 ion is not connected to the glycosylation modification, while the Y1 ion is connected to the glycosylation modification with a mass of 203.079Da, and the masses of the peptide segments of the two are equal), and the mass difference between the first and third ions (Y0 and Y2) is also 609.238Da. The three peaks are The three ions in the first row of the table above match each other), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da), and compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum;
[0068] If there are three peaks with masses of 500, 906.159, and 1109.238Da in a secondary spectrum, the mass difference between the first two peaks is 406.159Da, and the mass difference between the first and third peaks is 609.238Da. In the case of the nineteenth row in the table above, the mass difference between the first two ions (Y0 and Y2) is also 406.159Da (because the Y0 ion is not connected to the glycosylation modification, while the Y1 ion is connected to the glycosylation modification with a mass of 406.159Da, and the masses of the peptide segments of the two are equal), the mass difference between the first and third ions (Y0 and Y2) is also 609.238Da. The three peaks and the three ions in the first row of the table above), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da), and compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum;
[0069] In this way, the screening process of candidate glycosylation modifications based on the Y ion appearance pattern is completed; 8797 secondary spectra are obtained through this step, and these spectra can screen out at least one glycosylation modification by matching the Y ion appearance pattern, and each of these spectra corresponds to the range of candidate glycosylation modifications screened out in this step; in subsequent searches, the glycosylation modification database corresponding to these spectra is composed of these screened glycosylation modifications; for example, the glycosylation modification screened out by the spectrum in the above example is Hex(3)HexNAc(3), then the glycosylation modification database used for this spectrum in the database search in step (A-3) only contains Hex(3)HexNAc(3), but does not contain the 15 types in step (7); the 8797 secondary spectra obtained in this step are used for the search in step (10);
[0070] (A-3) for the 8797 secondary spectra screened in step (A-2), the glycosylation modifications in the candidate modification range are used as a new glycosylation modification database (such as the example in step (A-2), the new modification database only contains the glycosylation modification Hex(3)HexNAc(3), relative to the 15 types in (7)), and the human proteome database in step (7) is used as the protein database, the mass-to-charge ratio and intensity value information of the peaks in the secondary spectra are extracted, and the database is searched;
[0071] In the database search, the mass of glycosylation modification in the new glycosylation modification database (such as the example of step (A-2), Hex (3) HexNAc (3) modification) and the protein sequence information of the proteome database are used to generate theoretical spectra (the peptide backbone fragment ions are calculated from the protein sequence information, and the parent ion mass is obtained by the sum of the peptide mass and the modification mass, and a theoretical secondary spectrum with parent ion mass information is obtained) for subsequent database search; the mass-to-charge ratio and intensity information of the peaks in the theoretical spectrum generated by combining the human proteome database and the glycosylation modification database are compared and matched; the search is performed using MS-Decipher software; the tolerance of the parent ion is ±10ppm, and the tolerance of the daughter ion is ±20ppm; each spectrum is ranked The theoretical spectrum with the highest score can be used to identify the spectrum information of the O-GalNAc complete glycosylation modified peptide from the secondary mass spectrometry data; the peptide length range is 6 to 46 amino acids, and the parent ion valence range is 2+ to 6+; trypsin is selected for complete specificity, with a maximum of 3 missed cleavage sites on each peptide; carbamidomethylation on cysteine is set as a fixed modification, and oxidation on methionine, deamidation on asparagine and glutamine are set as variable modifications; a total of 2509 secondary spectra can be used to obtain results in this step; the remaining 6288 secondary spectra, as well as 59844 secondary spectra that were not matched to glycosylation modification through the Y ion appearance pattern in step (A-2), a total of 66132 secondary spectra, are used for retrieval in step (A-4);
[0072] (A-4) 59,844 secondary spectra that were not matched to glycosylation modification by matching the Y ion appearance pattern in step (A-2), and 6,288 secondary spectra that did not obtain search results in step (A-3), totaling 66,132 spectra; extracting the mass-to-charge ratio and intensity information of the peaks in these spectra, still using the 15 O-glycosylation modification compositions in step (7) as the glycosylation modification database and the human proteome database to generate theoretical spectra, and then comparing the theoretical spectra with the mass-to-charge ratio and intensity values of all the peaks in the 66,132 experimental spectra screened out, as well as the parent ion mass information of the secondary spectra with the parent ion mass information of the theoretical spectra, and performing a database search, selecting the matching theoretical spectrum with the highest Rank Score for each secondary spectrum, and searching using MS-Decipher software, and other search parameters are the same as those in step (A-3);
[0073] (A-5) The results of steps (A-3) and (A-4) were combined, and the false positive rate (FDR) was calculated using percolator software (version 3.6). The final results screened the PSM (peptide-spectrum matching) results with q-value and peptide q-value not greater than 0.01 and Rank Score not less than 20, and finally 2816 PSM results and 105 non-redundant O-glycosylated peptide sequences were obtained.
[0074] (B) For glycosylation modification with 2 glycosylation units (n=2) (Hex(1)HexNAc(1)):
[0075] (B-1) Based on the glycosylation modifications in step (7), list all possible Yn ions (Yn ions refer to complete peptide ions with partial glycosylation modifications, n represents the number of sugar units attached to the peptide ion, see the table below; Y1 to Y2 ions are listed here);
[0076]
[0077] These ions with different n values are combined in pairs with the Y0 ion (complete peptide backbone ion) to form the Y ion appearance pattern (see the table below); this step obtains different Y ion appearance patterns ([Y0 ion, Y1 ion, Y2 ion]), which are used to match the spectral peaks in the spectrum later. The matching process is shown in the next step;
[0078]
[0079] (B-2) The Y values of two different X values in these occurrence patterns are X The mass difference between the ion and the Y0 ion (two mass differences) is matched with the mass difference of the two larger mass peaks minus the smallest mass peak among all three peaks in the secondary spectrum. If the mass difference between the two unique peaks is equal to the mass difference between the two ions in the appearance pattern, the three peaks are considered to match the appearance pattern.
[0080] For example, if three peaks appear in a secondary spectrum that conform to a certain Y ion appearance pattern (for example, there are three peaks in a spectrum with masses of 400, 603.079, and 765.132Da, respectively, then the mass difference between the first two peaks is 203.079Da, and the mass difference between the first and third peaks is 365.132Da. In the case of the first row in the table above, the mass difference between the first two ions (Y0 and Y1) is also 203.079Da (because the Y0 ion is not connected to glycosylation modification, while the Y1 ion is connected to glycosylation modification with a mass of 203.079Da, and the masses of the peptide segments of the two are equal), the mass difference between the first and third ions (Y0 and Y2) is also 365.132Da, these three peaks match the three ions in the first row of the table above), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 400Da) and the parent ion (for example, the parent ion mass is 765.132Da, and the mass of the peak with the smallest mass is 400Da, then the mass difference is 365.132Da), compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 365.132Da, which is equal to the mass of the glycosylation modification Hex(1)HexNAc(1) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum;
[0081] In this way, the screening process of candidate glycosylation modifications based on the Y ion appearance pattern is completed; 10,587 secondary spectra are obtained through this step, and these spectra can screen out at least one glycosylation modification by matching the Y ion appearance pattern, and each of these spectra corresponds to the range of candidate glycosylation modifications screened out in this step; in subsequent searches, the glycosylation modification database corresponding to these spectra is composed of these screened glycosylation modifications; for example, the glycosylation modification screened out by the spectrum in the above example is Hex(1)HexNAc(1), then the glycosylation modification database used for this spectrum in the database search in step (B-3) only contains Hex(1)HexNAc(1), but does not contain the 15 types in step (7); the 2,685 secondary spectra obtained in this step are used for the search in step (10);
[0082] (B-3) For the 2685 secondary spectra screened in step (B-2), the glycosylation modifications in the candidate modification range are used as a new glycosylation modification database (such as the example in step (B-2), the new modification database only contains the glycosylation modification Hex(1)HexNAc(1), relative to the 15 types in (7)), and the human proteome database in step (7) is used as the protein database, the mass-to-charge ratio and intensity value information of the peaks in the secondary spectra are extracted, and the database is searched;
[0083] In the database search, the mass of glycosylation modification in the new glycosylation modification database (such as the example of step (B-2), Hex (1) HexNAc (1) modification) and the protein sequence information of the proteome database are used to generate theoretical spectra (the peptide backbone fragment ions are calculated from the protein sequence information, and the parent ion mass is obtained by the sum of the peptide mass and the modification mass, and a theoretical secondary spectrum with parent ion mass information is obtained) for subsequent database search; the mass-to-charge ratio and intensity information of the peaks in the theoretical spectrum generated by combining the human proteome database and the glycosylation modification database are compared and matched; the search is performed using MS-Decipher software; the tolerance of the parent ion is ±10ppm, and the tolerance of the daughter ion is ±20ppm; each spectrum is ranked The theoretical spectrum with the highest score can be used to identify the spectrum information of the O-GalNAc complete glycosylation modified peptide from the secondary mass spectrometry data; the peptide length range is 6 to 46 amino acids, and the parent ion valence range is 2+ to 6+; trypsin is selected for complete specificity, with a maximum of 3 missed cleavage sites on each peptide; carbamidomethylation on cysteine is set as a fixed modification, and oxidation on methionine, deamidation on asparagine and glutamine are set as variable modifications; a total of 217 secondary spectra can be used to obtain results in this step; the remaining 2468 secondary spectra, as well as 65956 secondary spectra that were not matched to glycosylation modification through the Y ion appearance pattern in step (B-2), a total of 68424 secondary spectra, are used for retrieval in step (B-4);
[0084] (B-4) In step (B-2), 65,956 secondary spectra that were not matched to glycosylation modification by matching the Y ion appearance pattern, and 2,468 secondary spectra that did not obtain search results in step (B-3), totaling 68,424 spectra; extracting the mass-to-charge ratio and intensity information of the peaks in these spectra, still using the 15 O-glycosylation modification compositions in step (7) as the glycosylation modification database and the human proteome database to generate theoretical spectra, and then comparing the theoretical spectra with the mass-to-charge ratio and intensity values of all the peaks in the 68,424 experimental spectra screened out, as well as the parent ion mass information of the secondary spectra with the parent ion mass information of the theoretical spectra, and performing a database search, selecting the matching theoretical spectrum with the highest Rank Score for each secondary spectrum, and searching using MS-Decipher software, and other search parameters are the same as those in step (B-3);
[0085] (B-5) The results of steps (B-3) and (B-4) were combined, and the false positive rate (FDR) was calculated using percolator software (version 3.6); the final results screened the PSM (peptide-spectrum matching) results with q-value and peptide q-value not greater than 0.01 and Rank Score not less than 20, and finally 288 PSM results and 11 non-redundant O-glycosylated peptide sequences were obtained;
[0086] (C) The results of step (A-5) and step (B-5) were combined to finally obtain 3104 PSM results and 116 non-redundant O-glycosylated peptide sequences.
[0087] Comparative Example:
[0088] The process and conditions are the same as those in the above embodiment, except that:
[0089] 1. Do not take steps (6)(8)(9)(10)(11)(12) of the example. Only use the mass spectrometry data obtained by steps (1-4) of the example (the data mentioned in (5) of the example), and use the glycosylation modification database (15 types) and the human proteome database in Example (7); compare and match the mass-to-charge ratio and intensity information of the peaks in the secondary spectrum in the mass spectrometry data, as well as the parent ion mass information of the secondary spectrum, with the theoretical spectra generated based on the glycosylation modification database (15 types) and the human proteome database, and perform database retrieval;
[0090] 2. The parameters used in the database matching step were the same as those in Example (10), except that the glycosylation modification database used in all spectrum searches contained all 15 glycosylation modifications (Example step (7)), and the search software used three other softwares:
[0091] MSFragger-Glyco (version 3.5, downloaded from https: / / msfragger.nesvilab.org / ), MetaMorpheus (version 0.0.320, downloaded from https: / / github.com / smith-chem-wisc / MetaMorpheus / releases), and pGlyco3 (version build20210615, downloaded from https: / / github.com / pFindStudio / pGlyco3 / releases) were used to perform database searches on the mass spectrometry data generated in step (5) of the embodiment. The above software All can be downloaded and used for free; the parent ion mass of the secondary spectrum and the mass-to-charge ratio and intensity information of all spectral peaks are still used in database retrieval, and matched with the parent ion mass and mass-to-charge ratio and intensity information of the spectral peaks of the theoretical spectrum; the theoretical spectrum is generated in the glycosylation database containing 15 glycosylation modifications and the human proteome database in step (7) of the embodiment; in the final result, each spectrum retains the theoretical spectrum matching result with the highest matching score, and retains the part with FDR not greater than 1%, and uses MSFragger-Glyco, MetaMorpheus, and pGlyco3 software for retrieval, and obtains 2690, 1585, and 1038 PSM results, respectively, and 97, 87, and 56 non-redundant O-glycopeptide sequences (attached to the instruction manual) Figure 2 );
[0092] Method evaluation:
[0093] Compared with several O-glycopeptide search software (MSFragger-Glyco, MetaMorpheus, pGlyco3) published in Nature Methods in recent years (such as Figure 2 ), this method can retrieve and identify 15.4%, 95.8%, and 199.0% of PSMs, as well as 19.6%, 33.3%, and 107.1% of non-redundant glycosylated peptide sequences. The above results illustrate the high sensitivity of this method.
Claims
1. A mass spectrometry method for identifying O-GalNAc glycosylated peptides in a protease hydrolysate, characterized in that: 1) Obtaining primary and secondary mass spectra of the protein hydrolysate; the spectrum identified by this method is the secondary spectrum; 2) First, by enumerating the appearance patterns of all possible complete peptide ions with partial glycosylation modifications (hereinafter referred to as "Y ions") in the mass spectrometry of O-GalNAc glycosylated peptides (hereinafter referred to as "O-glycopeptides"), the peptide ions include Y0, Y1 to Yn ions with 0 to n glycosylation units; n is an integer greater than or equal to 2, and 0, 1 or n respectively represent the number of glycosylation units in the peptide ions; "Yn" ion refers to a peptide ion with n glycosylation units, where n refers to the number of glycosylation units on the peptide in the ion; n is an integer greater than or equal to 2. In particular, Y0 ion refers to the complete peptide backbone ion (peptide ion) of O-glycopeptide. In theory, Y0 may appear in all glycopeptide spectra; Yn ion theoretically only appears in glycosylation-modified glycopeptide spectra with n glycosylation units. According to the structure of O-GalNAc glycosylation modification, O-GalNAc glycosylation is connected to the peptide through a HexNAc (N-acetylhexosamine). Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". For all O-GalNAc glycosylated peptides, this ion may appear in their spectra. As for the Yn ion, its structure can only be "peptide ion + HexNAc (1) + (n-1) glycosylation unit"; The occurrence pattern of "Y ions" only considers the Y0 ion and any other Y with different X values. X ion, X is an integer from 1 to n; 3) For O-glycosylated glycopeptides, the Y1 ion that may appear in the secondary spectrum is the peptide ion connected to HexNAc (1), and the mass of the Y1 ion is "the mass of the peptide ion (Y0 mass) + the mass of HexNAc (1)"; X The ion mass is "peptide ion mass (Y0 mass) + mass of X glycosylation units including HexNAc (1)"; The Y values of these two different X values in the pattern are X The mass difference between the ion and the Y0 ion (two mass differences) is matched with the mass difference between the two larger mass peaks minus the smallest mass peak among all three peaks in the secondary spectrum; The two mass differences (Y for two different X values in the pattern) are X The mass difference between the ion and the Y0 ion) is matched with the mass difference between all the peaks in the secondary spectrum (the mass difference between the two larger mass peaks minus the smallest mass peak in any three peaks as a group). If the mass difference between the two peaks in the selected group (the mass difference between the two larger mass peaks minus the smallest mass peak) is equal to the mass difference between the two ions in the appearance pattern (the mass difference between the two different X values of Y X ion and the mass difference of the Y0 ion), then the three peaks of this group are considered to match the appearance pattern; After matching the occurrence pattern, the p1 peak with the smallest mass among the three peaks matching the occurrence pattern is selected, and the candidate glycosylation modification is selected by calculating the mass difference between the ion peak and the mass of the parent ion of the secondary spectrum (known, the existing information in the secondary spectrum). If the mass difference between the parent ion mass and the p1 peak is equal to the mass of the glycosylation modification, the modification is used as the glycosylation modification to be searched (instead of using all the glycosylation modifications in the set glycosylation modification database); The modified mass and the protein sequence information of the proteome database of the species corresponding to the protein sample in the enzymatic hydrolyzate are used to generate a theoretical spectrum (the mass-to-charge ratio information and intensity information of the peptide backbone fragment ions are calculated from the protein sequence information, the mass-to-charge ratio information and the intensity information constitute the peaks in the theoretical secondary spectrum, the parent ion mass is obtained by the sum of the peptide mass and the modified mass, and a theoretical secondary spectrum with parent ion mass information is obtained) for subsequent database retrieval; in the database retrieval, the mass-to-charge ratio and intensity information of the peaks in the theoretical spectrum and the experimental secondary spectrum are matched, and the theoretical spectrum with the highest RankScore score matching the experimental spectrum is obtained as the theoretical spectrum matching result matching the experimental secondary spectrum, based on which the information of the O-GalNAc complete glycosylation modified peptide (peptide sequence and glycosylation modification identification information) can be obtained from the secondary mass spectrometry data.
2. The mass spectrometry identification method according to claim 1, characterized in that: The glycosylation unit may be one or more of hexose (Hex), HexNAc (N-acetylhexosamine), and sialic acid (NeuAc); O-GalNAc glycosylation is linked to the peptide through a HexNAc, so the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptide can only be in the form of "peptide ion + HexNAc (1)"; Theoretically, Yn ions (n is an integer greater than 0) will only appear in the spectrum of glycopeptides with n glycosylation units. For example, in the spectrum of the glycopeptide with O-glycosylation modification Hex(1)HexNAc(1) (n=2), only Y0, Y1, and Y2 ions will appear (because the number of glycosylation units in the glycosylation modification Hex(1)HexNAc(1) is 2, and it is impossible for Yn ions with n>2 to appear). In the spectrum of the glycopeptide with O-glycosylation modification Hex(1)HexNAc(1)NeuAc(1) (n=3), only Y0, Y1, Y2, and Y3 ions will appear (because the number of glycosylation units in the glycosylation modification Hex(1)HexNAc(1)NeuAc(1) is 3). According to the structure of O-GalNAc glycosylation modification (Reference 1. Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. 2015. Essentials of Glycobiology. In: Varki, A.; Cummings, RD; Esko, JD; Stanley, P.; Hart, GW; Aebi, M.; et al. (Eds.) 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring O-GalNAc glycosylation is linked to the peptide through a HexNAc. Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". This ion may appear in the spectrum of all O-GalNAc glycosylated peptides. As for the Y2 and Y3 ions, their structures can only be "peptide ion + HexNAc (1) + a glycosylation unit" and "peptide ion" respectively. + HexNAc(1) + two glycosylation units". For example, for the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), its Y1 ion has only one form, "peptide ion + HexNAc(1)", its Y2 ion has two forms, "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)", and its Y3 ion has only one form, "peptide ion + Hex(1)HexNAc(1)NeuAc(1)". For O-glycosylation modification Hex(1)HexNAc(1), the Y1 ion that may appear in the secondary spectrum of the glycopeptide with this glycosylation is the peptide ion with HexNAc(1) (the 1 in the bracket means that it contains 1), and its mass is "peptide ion mass (Y0 mass) + HexNAc(1) mass"; the Y2 ion that may appear is the peptide ion with Hex(1)HexNAc(1), and the 1 in the bracket means that it contains 1, and its mass is "peptide ion mass + Hex(1)HexNAc(1) mass"; then for this glycosylation, For glycosylation modification, "Y ion occurrence pattern" refers to the occurrence pattern consisting of three ions: [complete peptide backbone ion (Y0 ion) of O-glycopeptide, Y1 ion, and Y2 ion]. For glycosylation modification containing three or more glycosylation units, there may be a Y3 ion (peptide ion with three glycosylation units, such as "peptide ion + Hex(1)HexNAc(1)NeuAc(1)"). This method also considers matching the occurrence patterns of [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion]. In this method, the ions listed in "Occurrence pattern" are only ion types. For example, "Y2 ion" refers only to the complete peptide ion with two sugar units, while its specific structure may be in various situations. For example, for a peptide with the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), there are two possible Y2 ions, namely "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)", and the 1 in the bracket means that there is one. For a peptide with the glycosylation modification HexNAc(3), the possible Y2 ion is "peptide ion + HexNAc(2)", and the 2 in the bracket means that there are two. The possible Y3 ion is "peptide ion + HexNAc(3)", and the 3 in the bracket means that there are three. This method studies the occurrence pattern of Y ions in O-glycopeptides with O-glycosylation modifications containing 2 or more glycosylation units. O-glycosylation modifications containing only one glycosylation unit (such as HexNAc(1)) are not within the scope of this method because Yn ions with n greater than or equal to 2 cannot appear in the spectrum of such glycopeptides. In the Y ion occurrence pattern studied in this method, the maximum value of n in Yn ions is 3. For O-glycosylation modifications containing only two glycosylation units on the peptide, such as Hex(1)HexNAc(1), only [Y0 ion, Y1 ion, Y For O-glycosylation modifications with three glycosylation units on the peptide, the three occurrence modes of [Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] are considered; for glycosylation modifications with four or more glycosylation units, such as Hex(1)HexNAc(1)NeuAc(2), this method also only considers the three occurrence modes of [Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion]; The mass difference between any two ions in these occurrence patterns is matched with the mass difference between any two peaks in the secondary spectrum; for example, in [Y0 ion, Y1 ion, Y2 ion], the mass of Y1 ion is "peptide ion mass + HexNAc(1) mass", and the mass of Y2 ion is "peptide ion mass + HexNAc(2) mass", then the mass difference between Y1 and Y0 ions is the mass of HexNAc(1), and the mass difference between Y2 and Y0 ions is the mass of HexNAc(2); these two mass differences are matched with the mass differences between all peaks in the secondary spectrum. If the mass difference between any two of the three unique peaks is equal to the mass difference between the two ions in the occurrence pattern, If there is a mass difference between the two, then these three peaks are considered to match the appearance pattern; if there are three peaks p1, p2, and p3 (mass: p3>p2>p1), the mass difference between p2 and p1 is equal to the mass of HexNAc(1), and the mass difference between p3 and p1 is equal to the mass of HexNAc(2), then these three peaks are considered to match the appearance pattern of [Y0 ion, Y1 ion, Y2 ion] Y ion (it is considered that: p1 matches Y0 ion, p2 matches Y1 ion, p3 matches Y2 ion, the mass of p2 is equal to "the mass of p1 + the mass of HexNAc(1)", and the mass of p3 is equal to "the mass of p1 + the mass of HexNAc(2)"); After matching the occurrence pattern, the one with the smallest mass among the three peaks matching the occurrence pattern is selected (the p1 peak in the above example), and the candidate glycosylation modification is selected by calculating the mass difference between the ion peak and the mass of the parent ion of the secondary spectrum (known, the existing information in the secondary spectrum) (if the mass difference between the parent ion mass and the p1 peak is equal to the mass of the glycosylation modification Hex(3)HexNAc(3), the Hex(3)HexNAc(3) modification is used as the glycosylation modification to be searched, instead of using all the glycosylation modifications in the set glycosylation modification database; if other glycosylation modifications are matched by matching the occurrence pattern, these glycosylation modifications are also put into the range to be searched; (If three peaks p4, p5, and p6 appear and match the appearance pattern of [Y0 ion, Y1 ion, and Y3 ion], and the mass difference between the parent ion and p4 is equal to the mass of Hex(3)HexNAc(3), then the modification Hex(3)HexNAc(3) should be included in the search range in the database search; if three peaks p7, p8, and p9 appear and match the appearance pattern of [Y0 ion, Y2 ion, and Y3 ion], and the mass difference between the parent ion and p7 is equal to the mass of Hex(3)HexNAc(3), then the modification Hex(3)HexNAc(3) should be included in the search range in the database search; the examples in this paragraph are only used for illustration and are irrelevant to the context examples;) The mass of Hex(3)HexNAc(3) modification (if other glycosylation modifications are matched by the matching pattern, these other glycosylation modifications are also used in the database search) is used to generate a theoretical spectrum with the protein sequence information of the proteome database of the corresponding species (the mass-to-charge ratio information and intensity information of the peptide backbone fragment ions are calculated from the protein sequence information, and the mass-to-charge ratio information and intensity information constitute the peaks in the theoretical secondary spectrum. The parent ion mass is obtained by the sum of the peptide mass and the modification mass, and the theoretical secondary spectrum with the parent ion mass information is obtained) for subsequent database search; in the database search, the mass-to-charge ratio and intensity information of the peaks in the theoretical spectrum and the experimental secondary spectrum are matched to obtain the RankScore score matching the experimental spectrum (Reference 4. Mao, J.; You, X.; Qin, H.; Wang, C.; Wang, L.; Ye, M. 2019. A New Searching Strategy for the Identification of O-Linked Glycopeptides. Analytical Chemistry). 91:3852–3859.) The highest theoretical spectrum is used to reduce the number of O-glycosylation modification species to be searched in the identification of O-glycopeptides. Based on this, more spectral information of O-GalNAc complete glycosylation modified peptides can be identified from the secondary mass spectrometry data.
3. The mass spectrometry identification method according to claim 1, characterized in that: For the obtained secondary mass spectra, firstly, all the mass peaks in each secondary spectrum were sorted from high to low according to the signal intensity; for each secondary spectrum, if there was a glycosylation unit ion peak; HexNAc + (N-acetylhexosamine), mass-to-charge ratio 204.087), and the signal intensity value of at least one of these two ion peaks is in the top 10% of all mass spectrum peaks in the signal intensity ranking of this secondary spectrum, this secondary mass spectrum is regarded as the O-glycopeptide spectrum to be processed; these secondary spectra are used for subsequent identification.
4. The mass spectrometry identification method according to any one of claims 1 to 3, characterized in that: The specific steps are as follows: (1) The chromatographic and mass spectrometric data of O-glycopeptides were obtained by using an O-glycopeptide enrichment analysis method, wherein the process is as follows: using a protease hydrolyzate in human serum as a sample, using PNGase F to remove the N-glycosylation modification attached to the glycosylated peptide segment, enriching it using a hydrophilic interaction chromatography column, and then analyzing it using liquid chromatography tandem mass spectrometry to obtain mass spectrometric data; (2) For the secondary mass spectra obtained in step (1), firstly, all the mass peaks in each secondary spectrum are sorted from high to low according to the signal intensity; for each secondary spectrum, if there are two oxonium ion peaks (Hex + (Hexose), mass-to-charge ratio 138.054; HexNAc + (N-acetylhexosamine), mass-to-charge ratio 204.087), and the signal intensity value of at least one of these two ion peaks is in the top 10% of all mass spectrum peaks in the signal intensity ranking of this secondary spectrum, this secondary mass spectrum is regarded as the O-glycopeptide spectrum to be processed; these secondary spectra are used for subsequent identification; (3) The three most common O-glycosylation modifications occurring on O-glycopeptides in human serum (Hex(1)HexNAc(1), Hex(1)HexNAc(1)NeuAc(1), Hex(1)HexNAc(1)NeuAc(2), where NeuAc is sialic acid), with each O-glycopeptide having a maximum of three glycosylation modifications, were arranged and combined to obtain 15 O-glycosylation modification compositions; these O-glycosylation modification compositions were used as the O-glycosylation modification database to be searched; (4) The glycosylation unit may be one or more of hexose (Hex), sialic acid (NeuAc), etc.; First, by enumerating the appearance patterns of all possible complete peptide ions with partial glycosylation modification (hereinafter referred to as "Y ions") in the mass spectrometry of O-GalNAc glycosylated peptides (hereinafter referred to as "O-glycopeptides"), the peptide ions include Y0, Y1 to Yn ions with 0 to n glycosylation units; n is an integer greater than or equal to 2, and 0, 1 or n respectively represent the number of glycosylation units in the peptide ions; "Yn" ion refers to a peptide ion with n glycosylation units, where n refers to the number of glycosylation units on the peptide in the ion; n is an integer greater than or equal to 2. In particular, Y0 ion refers to the complete peptide backbone ion (peptide ion) of O-glycopeptide. In theory, Y0 may appear in all glycopeptide spectra; Yn ion theoretically only appears in glycosylation-modified glycopeptide spectra with n glycosylation units. According to the structure of O-GalNAc glycosylation modification, O-GalNAc glycosylation is connected to the peptide through a HexNAc (N-acetylhexosamine). Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". For all O-GalNAc glycosylated peptides, this ion may appear in their spectra. As for the Yn ion, its structure can only be "peptide ion + HexNAc (1) + (n-1) glycosylation unit"; The occurrence pattern of "Y ions" only considers the Y0 ion and any other Y with different X values. X ion, X is an integer from 1 to n; O-GalNAc glycosylation is connected to the peptide through a HexNAc. Therefore, the Y1 ion that appears in the spectrum of O-GalNAc glycosylated peptides can only be in the form of "peptide ion + HexNAc (1)". For all O-GalNAc glycosylated peptides, this ion may appear in their spectra (because the number of glycosylation units in glycosylation modification is at least 1). For Y2 and Y3 ions, their structures can only be "peptide ion + HexNAc (1) + one glycosylation unit" and " "peptide ion + HexNAc(1) + two glycosylation units"; for example, for the glycosylation modification Hex(1)HexNAc(1)NeuAc(1), its Y1 ion has only one form, "peptide ion + HexNAc(1)", its Y2 ion has two forms, "peptide ion + Hex(1)HexNAc(1)" and "peptide ion + HexNAc(1)NeuAc(1)", and its Y3 ion has only one form, "peptide ion + Hex(1)HexNAc(1)NeuAc(1)"; For O-glycosylation modification Hex(1)HexNAc(1), the Y1 ion that may appear in the secondary spectrum of the glycopeptide with this glycosylation is the peptide ion with HexNAc(1), and its mass is "peptide ion mass (Y0 mass) + HexNAc(1) mass"; the Y2 ion that may appear is the peptide ion with Hex(1)HexNAc(1), and its mass is "peptide ion mass + Hex(1)HexNAc(1) mass"; for this glycosylation modification, the "Y ion appearance pattern" refers to the complete peptide backbone ion (Y0 ion) of the O-glycopeptide, Y1 ion, Y2 ion]; for a glycosylation modification containing three glycosylation units, there may be a Y3 ion (a peptide ion with three glycosylation units, such as "peptide ion + Hex(1)HexNAc(1)NeuAc(1)"), and the appearance patterns of [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] may also be formed; based on these glycosylation modifications in step (3), list all possible Yn ions (Yn ion refers to a complete peptide ion with partial glycosylation modifications, and n represents the number of sugar units attached to the peptide ion); This method studies the appearance pattern of Y ions in O-glycopeptides with O-glycosylation modifications containing 2 or more glycosylation units. O-glycosylation modifications containing only one glycosylation unit (such as HexNAc(1)) are not within the scope of this method because Yn ions with n greater than or equal to 2 cannot appear in the spectrum of such glycopeptides. In the Y ion appearance pattern studied in this method, the maximum value of n in Yn ions is 3. For O-glycosylation modifications containing only two glycosylation units on the peptide, such as Hex(1)HexNAc(1), only the appearance pattern of [Y0 ion, Y1 ion, Y2 ion] is considered. For O-glycosylation modifications containing three or more glycosylation units on the peptide, three appearance patterns of [Y0 ion, Y1 ion, Y2 ion], [Y0 ion, Y1 ion, Y3 ion] and [Y0 ion, Y2 ion, Y3 ion] are considered. These ions with different n values are combined in pairs with the Y0 ion (complete peptide backbone ion) to form the Y ion appearance pattern (the brackets are different appearance patterns, and the brackets are the glycosylation modification and mass attached to the Yn ion): 1.[Y0,Y1,(HexNAc(1),203.079),Y2,(Hex(1)HexNAc(1),365.132)], 2.[Y0,Y1,(HexNAc(1),203.079),Y2,(HexNAc(1)NeuAc(1),494.175)], 3.[Y0,Y1,(HexNAc(1),203.079),Y2,(HexNAc(2),406.159)], 4.[Y0,Y1,(HexNAc(1),203.079),Y3,(Hex(1)HexNAc(1)NeuAc(1),656.228)], 5.[Y0,Y1,(HexNAc(1),203.079),Y3,(Hex(1)HexNAc(2),568.212)], 6.[Y0,Y1,(HexNAc(1),203.079),Y3,(HexNAc(2)NeuAc(1),697.254)], 7.[Y0,Y1,(HexNAc(1),203.079),Y3,(HexNAc(3),609.238)], 8.[Y0,Y2,(Hex(1)HexNAc(1),365.132),Y3,(Hex(1)HexNAc(1)NeuAc(1),656.228)], 9.[Y0,Y2,(Hex(1)HexNAc(1),365.132),Y3,(Hex(1)HexNAc(2),568.212)], 10.[Y0,Y2,(Hex(1)HexNAc(1),365.132),Y3,(HexNAc(2)NeuAc(1),697.254)], 11.[Y0,Y2,(Hex(1)HexNAc(1),365.132),Y3,(HexNAc(3),609.238)], 12.[Y0,Y2,(HexNAc(1)NeuAc(1),494.175),Y3,(Hex(1)HexNAc(1)NeuAc(1),656.228)], 13.[Y0,Y2,(HexNAc(1)NeuAc(1),494.175),Y3,(Hex(1)HexNAc(2),568.212)], 14.[Y0,Y2,(HexNAc(1)NeuAc(1),494.175),Y3,(HexNAc(2)NeuAc(1),697.254)], 15.[Y0,Y2,(HexNAc(1)NeuAc(1),494.175),Y3,(HexNAc(3),609.238)], 16.[Y0,Y2,(HexNAc(2),406.159),Y3,(Hex(1)HexNAc(1)NeuAc(1),656.228)], 17.[Y0,Y2,(HexNAc(2),406.159),Y3,(Hex(1)HexNAc(2),568.212)], 18.[Y0,Y2,(HexNAc(2),406.159),Y3,(HexNAc(2)NeuAc(1),697.254)], 19.[Y0,Y2,(HexNAc(2),406.159),Y3,(HexNAc(3),609.238)]] (5) The Y values of two different X values in these occurrence patterns X The mass difference between the ion and the Y0 ion (two mass differences) is matched with the mass difference between the two larger mass peaks minus the smallest mass peak among all three peaks in the secondary spectrum; Match these two mass differences with the mass differences between all the peaks in the secondary spectrum. If the mass differences between the two unique three peaks are equal to the mass differences between the two ions in the appearance pattern, then the three peaks are considered to match the appearance pattern. After matching the occurrence pattern, the peak with the smallest mass among the three peaks matching the occurrence pattern is selected, and the candidate glycosylation modification is selected by calculating the mass difference between the ion peak and the mass of the parent ion of the secondary spectrum (known, the existing information in the secondary spectrum) (if the mass difference between the parent ion mass and the peak with the smallest mass is equal to the mass of the glycosylation modification, the modification is used as the glycosylation modification to be searched, instead of using all the glycosylation modifications in the set glycosylation modification database; For example, in the O-glycopeptide spectrum screened by step (2), the peaks with the Y ion appearance pattern in step (4) are matched. If three peaks appear that meet a certain Y ion appearance pattern (for example, in a spectrum, there are three peaks with masses of 500, 703.079, and 906.159 Da, respectively, then the mass difference between the first two peaks is 203.079 Da, and the mass difference between the first and third peaks is 365.132 Da, and the mass difference between the first two ions (Y0 and Y1) in the case of appearance pattern 4 listed in step (4) is also 203.079 Da (because the Y0 ion is not connected to glycosylation modification, while the Y1 ion is connected to glycosylation modification with a mass of 203.079 Da, and the masses of the peptide segments of the two are equal), the first and third ions are The mass difference between the protons (Y0 and Y2) is also 406.159Da, and these three spectral peaks match the three ions in the case of occurrence mode 4 listed in step (4)). The mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion is calculated (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da). The mass difference is compared with the mass of each modification in the glycosylation modification database. If they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), the glycosylation modification is placed in the candidate modification range of this spectrum. If there are three peaks with masses of 500, 703.079, and 1109.238 Da, respectively, the mass difference between the first two peaks is 203.079 Da, and the mass difference between the first and third peaks is 609.238 Da. The mass difference between the first two ions (Y0 and Y1) in the case of mode 7 in step (4) is also 203.079 Da (because the Y0 ion is not connected to glycosylation modification, while the Y1 ion is connected to glycosylation modification with a mass of 203.079 Da, and the masses of the peptide segments of the two are equal), and the mass difference between the first and third ions (Y0 and Y2) is also 609.238 Da. These three peaks are consistent with step (4 ), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da), and compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum; If there are three peaks with masses of 500, 906.159, and 1109.238 Da, respectively, the mass difference between the first two peaks is 406.159 Da, and the mass difference between the first and third peaks is 609.238 Da. The mass difference between the first two ions (Y0 and Y2) in the case of pattern 19 exemplified in step (4) is also 406.159 Da (because the Y0 ion is not connected to glycosylation modification, while the Y1 ion is connected to glycosylation modification with a mass of 365.132 Da, and the masses of the peptide portions of the two are equal), and the mass difference between the first and third ions (Y0 and Y2) is also 609.238 Da. These three peaks are consistent with step (4 ), calculate the mass difference between the peak with the smallest mass (such as the first peak in the above example, with a mass of 500Da) and the parent ion (for example, the parent ion mass is 1595.397Da, and the mass of the peak with the smallest mass is 500Da, then the mass difference is 1095.397Da), and compare the mass difference with the mass of each modification in the glycosylation modification database; if they are equal (for example, the mass difference calculated in the above example is 1095.397Da, which is equal to the mass of the glycosylation modification Hex(3)HexNAc(3) in the glycosylation database), then put the glycosylation modification into the candidate modification range of this spectrum; In this way, the screening process of candidate glycosylation modifications based on the Y ion appearance pattern is completed; at least one glycosylation modification can be screened out from the secondary spectra obtained in this step, and each of these spectra corresponds to the range of candidate glycosylation modifications screened out in this step; for example, the glycosylation modification screened out by the spectrum in the above example is Hex(3)HexNAc(3), then the glycosylation modification database used for this spectrum in the database search in step (6) only contains Hex(3)HexNAc(3), but does not contain the 15 types in step (3); (6) For the secondary spectrum screened in step (5), the glycosylation modifications in the candidate modification range are used as a new glycosylation modification database (such as the example in step (5), the new modification database only contains the glycosylation modifications Hex(3)HexNAc(3), relative to the 15 types in (3)), and the human proteome database in step (3) is used as the protein database, the mass-to-charge ratio and intensity value information of the peaks in the secondary spectrum are extracted, and a database search is performed, and the mass-to-charge ratio and intensity value information of the peaks in the theoretical spectrum generated by combining the human proteome database and the glycosylation modification database are compared and matched; In the database search, the mass of the screened glycosylation modification (such as Hex(3)HexNAc(3) modification in the example of step (5)) and the protein sequence information of the proteome database are used to generate theoretical spectra (the peptide backbone fragment ions are calculated from the protein sequence information, and the parent ion mass is obtained by the sum of the peptide mass and the modification mass to obtain a theoretical secondary spectrum with parent ion mass information) for subsequent database search; the search is performed using MS-Decipher software; the parent ion tolerance is ±10ppm, and the daughter ion tolerance is ±20ppm; each spectrum is ranked The match with the highest score; the peptide length range is 6 to 46 amino acids, and the parent ion valence range is 2+ to 6+; trypsin is selected for complete specificity, with a maximum of 3 missed cleavage sites on each peptide; carbamidomethylation on cysteine is set as a fixed modification, and oxidation on methionine, deamidation on asparagine and glutamine are set as variable modifications; a total of 6452 secondary spectra can be obtained in this step; the remaining 4135 secondary spectra, as well as the secondary spectra that were not matched to glycosylation modification through the Y ion appearance pattern in step (5), are used for the search in step (7); (7) The secondary spectrum of glycosylation modification that was not matched by matching the Y ion appearance pattern in step (5) and the secondary spectrum for which no search results were obtained in step (6); The mass-to-charge ratio and intensity information of the peaks in these spectra are extracted, and the 15 O-glycosylation modification compositions in step (3) are still used as the glycosylation modification database and the human proteome database to generate theoretical spectra. The theoretical spectra are then compared and matched with the screened experimental spectra, and database retrieval is performed. The matching theoretical spectrum with the highest Rank Score is selected for each secondary spectrum, and the MS-Decipher software is used for retrieval. Other retrieval parameters are the same as those in step (6); (8) The results of steps (6) and (7) were combined, and the false positive rate was calculated using the percolator software (version 3.6). The final result screened the PSM (peptide-spectrum matching) results with q-value and peptide q-value not greater than 0.01 and Rank Score not less than 20.
